Takeki Myoren

A Low-Dose β<sub>1</sub>-Blocker Effectively and Safely Slows the Heart Rate in Patients with Acute Decompensated Heart Failure and Rapid Atrial Fibrillation

Shigeki Kobayashi, Wakako Murakami, Takeki Myoren et al. · Cardiology · 2013 · 35 citations

Urinary 8-hydroxy-2′-deoxyguanosine as a novel biomarker of inflammatory activity in patients with cardiac sarcoidosis

Shigeki Kobayashi, Takeki Myoren, Seiko Oda et al. · International Journal of Cardiology · 2015 · 29 citations

Inflammation, Cardiac Sarcoidosis, Inflammatory Activity +7

A Low-Dose β1-Blocker in Combination with Milrinone Improves Intracellular Ca2+ Handling in Failing Cardiomyocytes by Inhibition of Milrinone-Induced Diastolic Ca2+ Leakage from the Sarcoplasmic Reticulum

Shigeki Kobayashi, Takehisa Susa, Hironori Ishiguchi et al. · PLoS ONE · 2015 · 23 citations · Full text

An oxidative stress biomarker, urinary 8-hydroxy-2′-deoxyguanosine, predicts cardiovascular-related death after steroid therapy for patients with active cardiac sarcoidosis

Takeki Myoren, Shigeki Kobayashi, Seiko Oda et al. · International Journal of Cardiology · 2016 · 21 citations

Active Cardiac Sarcoidosis, Cardiorenal Syndromes, Cardiovascular Disease +10

Urinary 8-Hydroxy-2′-Deoxyguanosine as a Myocardial Oxidative Stress Marker Is Associated With Ventricular Tachycardia in Patients With Active Cardiac Sarcoidosis

Hironori Ishiguchi, Shigeki Kobayashi, Takeki Myoren et al. · Circulation Cardiovascular Imaging · 2017 · 17 citations